Early Phase 1 Multiple Sclerosis Trial, Recruiting NCT04634994 Sponsor: Brigham and Women's Hospital Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Early Phase 1 Multiple Sclerosis Trial, Recruiting

NCT04634994
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with multiple sclerosis (MS) — including primary progressive MS (PPMS), relapsing-remitting MS (RRMS), or secondary progressive MS (SPMS) — based on the 2017 McDonald diagnostic criteria
  • Healthy volunteers of a similar age and sex to MS participants, as a comparison group
  • People who are willing to undergo both PET and MRI brain scans as part of the study
  • People who are willing and able to give their formal agreement to take part in the trial

Who may not be able to join:

  • People who have another known neurological condition, a history of head injury, or a history of substance abuse
  • People who have bipolar disorder or schizophrenia
  • People who have other medical conditions that would make the study procedures unsafe (confirm with trial site)
  • Women who are pregnant, breastfeeding, trying to become pregnant, or who suspect they may be pregnant
  • People who experience claustrophobia (fear of enclosed spaces, which may affect the ability to undergo MRI or PET scanning)
  • People who have implanted medical devices that are not safe to use with MRI machines
  • People who have been treated with corticosteroids (a type of anti-inflammatory medication) within the past four weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Tarun Singhal, MD, Brigham and Women's Hospital

Phone: 617-264-3043

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Registry
ClinicalTrials.gov
Start date
14 May 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PET measurements in individuals with PMS, RRMS, and healthy controls

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov